Assertio is Restoring Lives One Story At A Time

Recent News

January 3, 2025

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)More News

December 17, 2024

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsMore News

December 13, 2024

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyRead More

​
More News